- Home
- SGMO vs CIO Comparison
SGMO vs CIO Comparison
Compare SGMO & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- CIO
- Stock Information
- Founded
- SGMO 1995
- CIO 2013
- Country
- SGMO United States
- CIO Canada
- Employees
- SGMO N/A
- CIO N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- CIO Real Estate Investment Trusts
- Sector
- SGMO Health Care
- CIO Real Estate
- Exchange
- SGMO Nasdaq
- CIO Nasdaq
- Market Cap
- SGMO 242.0M
- CIO 202.0M
- IPO Year
- SGMO 2000
- CIO 2014
- Fundamental
- Price
- SGMO $1.07
- CIO $4.92
- Analyst Decision
- SGMO Buy
- CIO
- Analyst Count
- SGMO 6
- CIO 0
- Target Price
- SGMO $5.17
- CIO N/A
- AVG Volume (30 Days)
- SGMO 3.8M
- CIO 130.5K
- Earning Date
- SGMO 03-12-2025
- CIO 02-20-2025
- Dividend Yield
- SGMO N/A
- CIO 8.13%
- EPS Growth
- SGMO N/A
- CIO N/A
- EPS
- SGMO N/A
- CIO N/A
- Revenue
- SGMO $52,291,000.00
- CIO $171,126,000.00
- Revenue This Year
- SGMO N/A
- CIO N/A
- Revenue Next Year
- SGMO N/A
- CIO $0.20
- P/E Ratio
- SGMO N/A
- CIO N/A
- Revenue Growth
- SGMO N/A
- CIO N/A
- 52 Week Low
- SGMO $0.30
- CIO $4.02
- 52 Week High
- SGMO $3.18
- CIO $6.50
- Technical
- Relative Strength Index (RSI)
- SGMO 37.60
- CIO 39.92
- Support Level
- SGMO $1.07
- CIO $4.84
- Resistance Level
- SGMO $1.24
- CIO $5.31
- Average True Range (ATR)
- SGMO 0.09
- CIO 0.16
- MACD
- SGMO 0.02
- CIO -0.00
- Stochastic Oscillator
- SGMO 5.71
- CIO 17.02
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. The company owns office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.